OR WAIT null SECS
February 01, 2020
CDMOs must consider challenges associated with the complexity of contract pharmaceutical manufacturing when approaching digitalization projects.
CDMOs and CMOs will continue to invest in biopharmaceutical services and facilities as the bio/pharmaceutical industry looks to biosimilars and personalized medicine.
January 09, 2020
Phillips-Medisize has announced that it is expanding its current Global Innovation and Development (GID) site in Struer, Denmark, to include a dedicated manufacturing development and clinical build unit.
December 05, 2019
Catalent and Ethicann Pharmaceuticals have announced a partnership aimed at developing a new combination pharmaceutical-grade CBD and THC product to treat MS spasticity using Catalent’s orally disintegrating tablet technology.
November 25, 2019
The companies announced a commercial supply agreement following FDA’s accelerated approval.
November 22, 2019
New training facilities, laboratories, packaging, gene therapy manufacturing, and biologics manufacturing highlight Thermo Fisher Scientific expansions.
Lubrizol Life Science Health adopts new name and opens commercial manufacturing facility.
November 02, 2019
Unforeseen challenges can be avoided in technology transfer by evaluating the variety of processes involved.
Contract manufacturers are making strategic partnerships and expanding services in the last quarter of 2019.
October 11, 2019
During the first day of CPhI Worldwide in Frankfurt, Germany, a panel of experts will be discussing the evolution of CDMOs in the shifting therapeutic landscape.